WELCOME TO THE
2021 ISV ANNUAL VIRTUAL CONGRESS

The International Society for Vaccines (ISV) is pleased to announce the 2021 ISV Annual Virtual Congress will take place on September 13 -15. The Congress will include pre-recorded and live sessions in different focus areas beginning with two keynote addresses and an introduction of the new ISV fellows, followed by multiple scientific sessions. While the exact details will be determined later, sessions will include executive summaries via pre-recorded tracks, live Q&A sessions with speakers, presentations selected from submitted abstracts, dedicated poster sessions, and a variety of highly interactive meetings. Participants will be able to meet and talk with their Fellow(s) of choice, select their favorite masterclass(es), and attend one or more workshops of interest.

We invite registrants to submit an abstract for a possible pre-recorded oral or poster presentation. Abstracts will be reviewed by our Scientific Committee (SC) outlined below. We also invite those who are interested in presenting a poster to submit a brief 2-3-minute introduction video once the SC accepts the abstract. The traditional Oral Abstract presentations selected by the SC will have the opportunity to give a 10-15 min presentation at one of the plenary sessions. Please scroll down to the abstract submission section for the link to instructions and to submit your abstract.  

Additionally, selected outstanding oral and poster presentations from the Congress will be invited to contribute an article (Research paper, Review or Commentary) based on the presented work in a Special Issue of the journal Human Vaccines and Immunotherapeutics (HV&I) where previous ISV congress special issues are published.

Please check back regularly as we will be making continual updates on the agenda and Congress design.

We are looking forward to making this an unforgettable, exciting & interactive event!

Warm regards,
Manon Cox on behalf of the co-chairs and scientific committee 

Read More

Congress Chairs

Manon Cox Congress Chair ISV / NextWaveBio - USA
Laura Palomares Congress Co-Chair National Autonomous University of Mexico-Mexico
Guus Rimmelzwaan Congress Co-Chair The University of Veterinary Medicine Hannover-Germany

Keynote Speakers

Ian Lipkin Columbia University-USA
Peter Hotez National School of Tropical Medicine-USA
Albert Osterhaus The University of Veterinary Medicine Hannover-DE

Invited Speakers

Esteban Corley Abxience-AR
Peter Dull Bill & Melinda Gates Foundation-USA
Mireli Fino MassBiologics of UMMS-USA
Angus Forster Vaxxas-AU
Rogerio Gaspar World Health Organization-PT
Cyril Gay USA
Jon HeinrichsSanofi Pasteur-USA
Subhash Kapre Inventprise LLC-USA
Neil King University of Washington-USA
Florian Krammer Icahn School of Medicine at Mount Sinai-USA
Madhavan Nallani ACM Biolabs-SG
Colin Pouton Monash University-AU
Michael Princiotta EpiVax Therapeutics, Inc.-USA
Sergio Valentinotti Liomont- CDMX
Andres Wigdorovitz Bioinnovo SA-AR

Meet The Fellows

Manon Cox NextWaveBio-USA
Ted Ross University of Georgia-USA
Denise Doolan James Cook University-AU
Shan Lu UMASS Medical School -USA
David WeinerThe Wistar Institute-USA
Sarah GilbertUniversity of Oxford-UK
Linda KlavinskisKing’s College London- UK
Xavier SaelensGhent University-BE
Margaret LiuProTherImmune-USA
Gary Kobinger Laval University-CAN
Tonya Villafana AstraZeneca-USA
Annie De Groot EpiVax-USA

Masterclass Speakers

Barry Buckland BiologicB-USA
Katherine Kedzierska University of Melbourne-AU
Janet Rose Rea AVM Biotechnology-USA
Indresh SrivastavaNovavax-USA

2021 SCIENTIFIC COMMITTEE

  • Randy Albrecht, Mount Sinai- USA
  • Denise Doolan, James Cook University-Australia
  • Amy Espeseth, Merck-USA
  • Lars Frelin, Karolinska Institutet-Sweden
  • Nathalie Garcon, BioAster-France
  • Alejandro Gil, Sinergium-Argentina
  • Gary Grohmann, Australia
  • Ruvim Izikson, Sanofi Pasteur-USA
  • Kathrin Jansen, Pfizer-USA
  • Linda Klavinskis, King’s College London-UK
  • Margaret Liu, ProTherimmune-USA
  • Shan Lu, UMass Medical School-USA
  • Linda Lua, Queensland University-Australia
  • Lenny Moise, Epivax-USA
  • Peter Nara, Biological Mimetics-USA
  • Sanjay Phogat,GSK-USA
  • Punnee Pitisuttithum, Mahidol University- Thailand
  • Joon Haeng Rhee, Chonnam National University-Korea
  • Matthias Schnell, Thomas Jefferson University-USA
  • Indresh Srivastava, Novavax-USA
  • David Weiner, Wistar Institute, USA
  • Yu-Mei Wen, Fudan University-Shanghai

REGISTRATION

Please pre-register for the 2021 ISV Annual Virtual Congress by clicking the registration button (free for pre-registration). You will receive your official login information via email upon completion. Be sure to save this information as you will need it to login to the Live Event.

The deadline to pre-register is September 1. Pre-registration now will allow you to receive all email updates related to Congress organization and preview the Congress design.

Attending the three-day ISV Annual Congress (September 13-15, 2021) is a paid event and registration rates are listed below. In addition to pre-registering, please choose your rate below (subject to verification) and click the associated link to complete your payment. If payment is not received your login will become deactivated and you will not be able to enter the Live Event on September 13-15th.

Active ISV members will receive a $100 discount to the listed registration fee (ISV one-year membership is $100). Student/postdoc members will receive a $35 discount (ISV one-year student membership is $35). We encourage everyone to become an ISV member to take advantage of the reduced rates and more member benefits. You may do so by visiting www.isv-online.org.

Type of Delegates Non-ISV Member ISV Member
Academic/Government/NGO US$180
ISV Non-Member Academic Rate
US$80
ISV Member Academic Rate
Industry US$280
ISV Non-Member Industry Rate
US$180
ISV Member Industry Rate
Student US$80
ISV Non-Member Student Rate
US$45
ISV Member Student Rate

Please email info@isvcongress.org with any questions

Abstract Submission

Abstract submission is open now! The deadline for regular submission is July 20. The submission of an abstract is free but attending ISV 2021 Annual Virtual Congress requires paid registration. Please note the abstract process will be the same as our previous in-person Congresses. Once submitted, your abstract will be reviewed by the Scientific Committee. Based on their review a small percentage will be selected to give a pre-recorded oral presentation which will be included in the Congress program. Other accepted abstracts will be presented as posters for our virtual poster sessions. If you are selected for a poster presentation you have the option to include a 2–3-minute introduction video. More details on oral and poster abstracts will be announced in the weeks ahead. Please submit your abstract by clicking below. Be sure to follow the instructions noted at the top of the submission page.

Agenda

Eastern Timezone

08:20-08:30

THEME OF THE DAY

Guus Rimmelzwaan
The University of Veterinary Medicine Hannover
08:30‐09:30

OPENING SESSION & INTRODUCTION *LIVE*


Session Chair:
Manon Cox
ISV/NextWaveBio
Welcome
Ted Ross
President, ISV

Mind the GAPP: A Vision for Ending Pandemics (includes LIVE Q &A)

KEYNOTE SPEAKER 1
W. Ian Lipkin
Columbia University
09:30-11:00

PLENARY SESSION 1: NEW VACCINES ON THE HORIZON

David Weiner
The Wistar Institute
Sanjay Phogat
GSK

RSV Immunization Approaches for Infants and Children

Jon Heinrichs
Sanofi Pasteur

HA Stalk and NA-Based Next Generation Influenza Virus Vaccines

Florian Krammer
Icahn School of Medicine at Mount Sinai

Efficient Selection of Tumor Associated Neoantigens in the Design of Personalized Cancer Vaccines

Michael Princiotta
EpiVax Therapeutics
11:00-11:30

QUESTION AND ANSWER SESSION ON PLENARY SESSION 1 *LIVE*

11:30‐12:00

POSTER SESSION 1

12:00-13:30

PLENARY SESSION 2: NEW DEVELOPMENTS IN TECHNOLOGY

Lenny Moise
EpiVax
Amy Espeseth
Merck

Computational Design of Nanoparticle Vaccines for Influenza Viruses, Coronaviruses, and Beyond

Neil King
University of Washington

Delivery of mRNA Vaccines - Current Status and Future Opportunities

Colin Pouton
Monash University

Vaxxas’ High Density Micro-Projection Array Patch (HD-MAP) – Delivering the Future of Needle-Free Vaccination

Angus Forster
Vaxxas
13:30-14:00

QUESTION AND ANSWER SESSION ON PLENARY SESSION 2 *LIVE*

14:00-14:30

SELECT YOUR MASTERCLASS 1 – T-CELL IMMUNOLOGY

Katherine Kedzierska
University of Melbourne
14:30-15:00

MEET THE FELLOWS 1

David Weiner
The Wistar Institute
Sarah Gilbert
University of Oxford-UK
15:00-15:30

SELECT YOUR MASTERCLASS 2 – INNOVATION & MANUFACTURING OF COVID VACINES

Barry Buckland
BiologicB
15:30-16:00

MEET THE FELLOWS 2

Linda Klavinskis
King’s College London
Xavier Saelens
Ghent University
08:20-08:30

THEME OF THE DAY

Laura Palomares
National Autonomous University of Mexico
08:30‐09:10

KEYNOTE SPEAKER 2: Vaccine Diplomacy in a Time of Antiscience

Peter Hotez
National School of Tropical Medicine
09:10-10:30

PLENARY SESSION 3: VACCINE MANUFACTURING & QUALITY CONTROL

Linda Lua
Queensland University
Indresh Srivastava
Novavax

Leveraging Vaccine Manufacturing and Quality Control Platforms for New Modalities, MassBiologics Experience

Mireli Fino
MassBiologics

Vaccine Production in Emerging Economies, Challenges and Opportunities

Sergio Valentinotti
Liomont
Esteben Corley
mAbxience

ORAL ABSTRACT 1

DNA Delivery of Immune‐Focused SARS‐CoV‐2 Nanoparticle Vaccines Drives Rapid and Potent Immunogenicity and Achieves Single‐Dose Protection

Kevin Liaw
The Wistar Institute

ORAL ABSTRACT 2

An mRNA vaccine against SARS‐CoV‐2: Polyethylene Glycol‐free, liposome‐based vaccine candidate EG‐COVID induces high levels of virus neutralizing antibodies

H. Christian Hong
EyeGene INC.
10:30-11:00

QUESTION AND ANSWER SESSION ON PLENARY SESSION 3 *LIVE*

11:00-11:45

Meet The Fellows Session 3 – Everything About ISV

Manon Cox
ISV/NextWaveBio
Ted Ross
ISV/University of Georgia
Denise Doolan
ISV/James Cook University
Shan Lu
ISV/UMMS
11:45-12:30

POSTER SESSION 2

12:30-14:00

PLENARY SESSION 4: REGULATION IN TIMES OF PANDEMICS & VACCINE HESITANCY + ORAL ABSTRACT SELECTIONS

Gary Grohmann
Scientific Advisor
Lars Frelin
Karolinska Institutet

Pandemics and Health Urgency of Innovation

Rogerio Gaspar
WHO

ORAL ABSTRACT 3

Perception of Vaccination of Filipino Mothers in the NCR Area Post‐Dengvaxia

Naomi Pompa
University of Santo Tomas

ORAL ABSTRACT 4

High Throughput Biosensor Technology to Establish Dosing Frequency and Concentration for an mRNA‐LNP Genital Herpes Vaccine


Lauren Hook
University of Pennsylvania

ORAL ABSTRACT 5

T Cell Epitope Content Comparison (EpiCC) Analysis Between PCV2 Vaccines and Field Strains

Andres Gutierrez
EpiVax

ORAL ABSTRACT 6

Improved Protection Against Multidrug Pseudomonas Aeruginosa Following Administration of an Fc Engineered DNA‐encoded Monoclonal Antibody (DMAb) with Enhanced Complement Activity

Jihae Choi
The Wistar Institute
14:00-14:30

QUESTION AND ANSWER SESSION ON PLENARY SESSION 4 *LIVE*

15:00-15:30

MEET THE FELLOWS 4

Margaret Liu
ProTherImmune
Gary Kobinger
Laval University
15:30-16:00

SELECT YOUR MASTERCLASS 3 – VACCINE CHARACTERIZATION AND ANALYTICS

Indresh Srivastava
Novavax
16:00-17:00

ISV Annual Meeting *LIVE*

08:20-08:30

THEME OF THE DAY

Manon Cox
ISV/NextWaveBio
08:30‐09:10

KEYNOTE SPEAKER 3: Preparing for the Next Pandemic in a One Health Approach

Albert Osterhaus
The University of Veterinary Medicine Hannover
09:10-10:30

PLENARY SESSION 5: ONE WORLD; ONE HEALTH VETERINARY VACCINES

Alejandro Gil
Sinergium
Randy Albrecht
Icahn School of Medicine at Mount Sinai

The Research and Development of Veterinary Vaccines from a Biodefense and One Health Perspective

Cyril Gay
USDA ARS

Next Generation Vaccine Platform: Polymersomes as Stable Nanocarriers for a Highly Immunogenic and Durable SARS-CoV-2 Spike Protein Subunit Vaccine

Madhavan Nallani
ACM Biolabs

Innovation in Veterinary Vaccines: Our Experience in the Development of a Targeted Vaccine for BVDV and Virus Like Particles for FMDV

Andres Wigdrovitz
INTA -CONICET- Bioinnovo SA
10:30-11:00

QUESTION AND ANSWER SESSION ON PLENARY SESSION 5 *LIVE*

11:00‐11:30

SELECT YOUR MASTERCLASS 4 – THE CONCEPTS OF GCP

Janet Rose Rea
AVM Biotechnology
12:00-12:30

MEET THE FELLOWS 5

Annie De Groot
EpiVax
Tonya Villafana
AstraZeneca
12:30-13:30

PLENARY SESSION 6: GLOBAL HEALTH AND FUNDING OF VACCINE DEVELOPMENT

Linda Klavinskis
King’s College London
Nathalie Garcon
BioAster

Challenges in Establishing Vaccine Manufacturing from a Research Set Up

Subhash Kapre
Inventprise

Correlates of Protection for COVID-19: What We’ve Learned So Far

Peter Dull
Bill & Melinda Gates Foundation
13:30-14:00

QUESTION AND ANSWER SESSION ON PLENARY SESSION 6 *LIVE*

14:00-14:15

CLOSING SESSION & 2022 ISV Congress *LIVE*

Manon Cox
ISV/NextWaveBio
Denise Doolan
ISV/James Cook University
Joon Rhee
Chonnam National University
Gary Kobinger
Laval University
Shan Lu
ISV/UMMS

Frequently Asked Questions

The International Society for Vaccines (ISV) is a not-for-profit organization that engages, supports, and sustains the professional goals of a diverse membership in all areas relevant to vaccines. ISV promotes the development and the use of vaccines/immunity to prevent and control infectious and non-infectious diseases in humans and animals. ISV also supports the career development of scientists in the field of vaccinology, including trainees.
The ISV Annual Congress is the world's largest non‐commercial scientific meeting covering all aspects of vaccine policy and public health, research and development of vaccine and immunotherapies for both human and zoonotic diseases. The conference serves as a platform to bring together individuals from all sectors of the global vaccine community to hear about the latest advances in the field, discuss challenges and opportunities, and network. ISV has hosted conferences all over the globe including USA, France, and Belgium.
YYes. Pre-Registering will allow you to view the Congress design and receive all meeting updates.
Yes. We will send you a separate payment link for you to pay your registration fee.
YYou will be able to pre-register for the Congress up until September 1, 2021.
Please follow the instructions and click the link in the abstract section above to submit your abstract.
The regular abstract submission deadline is July 20, 2021.
Your abstract will be reviewed by our Scientific Committee. A selected few will be given the opportunity to give an oral presentation as part of the official program. Other accepted abstracts will be invited to give a poster presentation.
You only need to have access to the Internet. You do not need to download or install any software.

Partners

Sponsors

Diamond

Platinum

Gold

Silver